Protagenic Therapeutics, Inc. (PTIX) DCF Valuation

Protagenic Therapeutics, Inc. (PTIX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Protagenic Therapeutics, Inc. (PTIX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Protagenic Therapeutics, Inc. (PTIX) valuation analysis using our sophisticated DCF Calculator! Loaded with authentic PTIX data, this Excel template empowers you to adjust forecasts and assumptions, enabling you to compute the intrinsic value of Protagenic Therapeutics, Inc. (PTIX) with accuracy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -2.1 -2.6 -4.1 -3.4 -4.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -2.1 -2.6 -4.1 -3.4 -4.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .8 .7 10.4 8.0 4.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .2 .1 .3 .2 .1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.1 -2.8 -4.6 -3.5 -4.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -1.9 -2.8 -4.4 -3.6 -4.7 -.1 .0 .0 .0 .0
WACC, % 5.63 5.63 5.63 5.63 5.63 5.63 5.63 5.63 5.63 5.63
PV UFCF
SUM PV UFCF -.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -1
Equity Value 1
Diluted Shares Outstanding, MM 4
Equity Value Per Share 0.27

What You Will Get

  • Pre-Filled Financial Model: Protagenic Therapeutics’ actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Instant Calculations: Real-time updates ensure you view results as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • Comprehensive Data: Protagenic Therapeutics, Inc. (PTIX) provides detailed historical financial statements and robust forecasts.
  • Customizable Parameters: Adjust inputs such as discount rates, tax rates, revenue projections, and operating margins.
  • Real-Time Insights: Instantly view the recalculated intrinsic value of Protagenic Therapeutics, Inc. (PTIX).
  • Intuitive Visualizations: User-friendly dashboard charts present valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the comprehensive Excel file containing Protagenic Therapeutics, Inc.'s (PTIX) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you input data.
  • Test Scenarios: Generate various forecasts and evaluate different outcomes immediately.
  • Make Decisions: Leverage the valuation insights to inform your investment choices.

Why Choose This Calculator for Protagenic Therapeutics, Inc. (PTIX)?

  • Designed for Experts: A sophisticated tool tailored for researchers, investors, and financial analysts.
  • Comprehensive Data: Protagenic Therapeutics’ historical and projected financials integrated for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Detailed instructions lead you through each step seamlessly.

Who Should Use This Product?

  • Investors: Assess the fair value of Protagenic Therapeutics, Inc. (PTIX) to make informed investment choices.
  • CFOs: Utilize a sophisticated DCF model for accurate financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports specific to Protagenic Therapeutics, Inc. (PTIX).
  • Entrepreneurs: Learn about financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a resource for teaching valuation techniques in the biotechnology sector.

What the Template Contains

  • Pre-Filled Data: Includes Protagenic Therapeutics’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Protagenic Therapeutics’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

Es wurden keine passenden Produkte gefunden.